Your browser doesn't support javascript.
loading
Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma.
Purdue, M P; Lan, Q; Kemp, T J; Hildesheim, A; Weinstein, S J; Hofmann, J N; Virtamo, J; Albanes, D; Pinto, L A; Rothman, N.
Afiliación
  • Purdue MP; 1] Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA [2] Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Lan Q; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Kemp TJ; HPV Immunology Laboratory, Leidos Biomedical Incorporated, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Hildesheim A; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Weinstein SJ; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Hofmann JN; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Virtamo J; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.
  • Albanes D; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Pinto LA; HPV Immunology Laboratory, Leidos Biomedical Incorporated, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Rothman N; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA.
Leukemia ; 29(6): 1429-31, 2015 Jun.
Article en En | MEDLINE | ID: mdl-25567136

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Biomarcadores de Tumor / Receptores de IgE / Antígeno Ki-1 Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2015 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Biomarcadores de Tumor / Receptores de IgE / Antígeno Ki-1 Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2015 Tipo del documento: Article